Detalhe da pesquisa
1.
Prolonged dopamine D3 receptor stimulation promotes dopamine transporter ubiquitination and degradation through a PKC-dependent mechanism.
Pharmacol Res
; 165: 105434, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33484816
2.
Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system.
Neurobiol Dis
; 88: 44-54, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26777664
3.
Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.
Neurobiol Dis
; 74: 325-35, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25511804
4.
Expression of RAD9B in the mesostriatal system of rats and humans: Overexpression in a 6-OHDA rat model of Parkinson's disease.
Ann Anat
; 250: 152135, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37460044
5.
Drastic decline in vasoactive intestinal peptide expression in the suprachiasmatic nucleus in obese mice on a long-term high-fat diet.
Brain Res Bull
; 202: 110756, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37678442
6.
Differential N termini in epithelial Na+ channel δ-subunit isoforms modulate channel trafficking to the membrane.
Am J Physiol Cell Physiol
; 302(6): C868-79, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22159085
7.
The dopamine transporter is differentially regulated after dopaminergic lesion.
Neurobiol Dis
; 40(3): 518-30, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20688165
8.
DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis.
Autophagy
; 16(7): 1279-1295, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31538542
9.
Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease.
Neurobiol Dis
; 36(3): 494-508, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19766189
10.
Phenotype, compartmental organization and differential vulnerability of nigral dopaminergic neurons.
J Neural Transm Suppl
; (73): 21-37, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-20411765
11.
Interleukin-6 and nitric oxide synthase expression in the vasopressin and corticotrophin-releasing factor systems of the rat hypothalamus.
J Histochem Cytochem
; 54(4): 427-41, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16322601
12.
Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.
J Comp Neurol
; 479(2): 198-215, 2004 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-15452855
13.
Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons.
Front Neuroanat
; 8: 84, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25206324
14.
Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.
Front Neuroanat
; 4: 140, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21079748
15.
Aging effects on the dopamine transporter expression and compensatory mechanisms.
Neurobiol Aging
; 30(6): 973-86, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17976862
16.
Deglycosylation and subcellular redistribution of VMAT2 in the mesostriatal system during normal aging.
Neurobiol Aging
; 29(11): 1702-11, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17582657
17.
Aging of the rat mesostriatal system: differences between the nigrostriatal and the mesolimbic compartments.
Exp Neurol
; 204(1): 147-61, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17112516
18.
Cloning and functional expression of a new epithelial sodium channel delta subunit isoform differentially expressed in neurons of the human and monkey telencephalon.
J Neurochem
; 102(4): 1304-15, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17472699
19.
Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells.
Eur J Neurosci
; 21(7): 1815-27, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15869477